Contract Deobligations Alert — August 05, 2026

Leidos secured a $318.4 million time-and-materials BPA call from U.S. Customs and Border Protection for IT application development support services, with $184.3 million (58%) already outlayed within the first year, indicating rapid execution and strong demand for border security IT modernization.

TriWest's $983.9 million firm-fixed-price VA delivery order has a performance period of only June 2026, creating a high-risk revenue recognition profile with zero outlayed funds to date, despite the large obligation.

Icahn School of Medicine at Mount Sinai received a $186.2 million cost-no-fee contract from the CDC for a Clinical Center of Excellence, with potential value of $340.8 million over 8 years, providing stable but zero-profit revenue for a nonprofit institution.

TriWest Healthcare's $983.9M VA contract has a one-month performance period (June 2026) with zero outlayed funds, creating material execution risk if the contract is not fully funded or delivered on time.

All five contracts are civilian (0% defense), creating concentration risk for investors seeking defense exposure. The portfolio is heavily weighted toward healthcare (TriWest, Icahn) and IT services (Leidos), with no alignment to NDAA priorities.

Leidos' $318.4M DHS task order was awarded under full and open competition, and the 53 subawards ($77.8M) suggest complex delivery requirements that could face protest or recompete risk.

The VA's $983.9M obligation to TriWest signals sustained or increased spending on veteran healthcare benefits, suggesting follow-on contracts or extensions for health insurance administration services.

Leidos' rapid outlay rate (58% in first year) on the $318.4M DHS IT task order indicates strong demand for traveler vetting software, potentially leading to contract modifications or new task orders for border security IT modernization.

The absence of defense contracts in this batch suggests potential underweight in defense exposure. Investors should monitor DOD contract awards for companies like Leidos, Lockheed Martin, and others that also serve civilian agencies.

Two of the five contracts (TriWest $983.9M VA, Icahn $186.2M CDC) total $1.17 billion in healthcare-related obligations, indicating strong government investment in veteran health insurance and clinical research centers, despite the absence of defense spending.

Leidos' $318.4M task order for traveler processing vetting software, with 58% outlayed in the first year, demonstrates DHS/CBP's commitment to upgrading IT systems for border security, a trend likely to continue given immigration policy focus.

{"entity" => "TriWest Healthcare Alliance Corp.", "reason" => "$983.9M VA contract with one-month performance period and zero outlayed funds creates high execution risk and potential for contract modification or cancellation.", "trigger" => "Outlayed funds status update, contract extension announcement, VA budget cycle"}

{"entity" => "Leidos, Inc.", "reason" => "$318.4M DHS IT task order with strong execution (58% outlayed) could lead to modifications or new task orders for border security IT.", "trigger" => "Option exercise, re-compete announcement (current end date: May 2027), DHS budget allocation"}

{"entity" => "Icahn School of Medicine at Mount Sinai", "reason" => "$186.2M CDC contract with potential $340.8M value over 8 years; option exercises will signal funding stability.", "trigger" => "Option exercise announcements, CDC budget for clinical research"}